Tsuchida and Vasic in 30 Under 30

photos of Tsuchida and Vasic

PhD alumni Connor Tsuchida and Ivana Vasic have both been named to the annual Forbes 30 Under 30 list for their achievements in Healthcare! Tsuchida has founded Crispr delivery startup Azalea Therapeutics, and Vasic is developing therapies to support the next generation of in vitro fertilization as founder of Vitra Labs.

Read More

Two alumni innovations named to Time 2023 Best Inventions

cover of Time Magazine Best Inventions of 2023 issue

Two PhD alumni have innovations named to the Time Magazine 200 Best Inventions of 2023 list. The Cala kIQ, developed by Cala Health, founded by alumna Kate Rosenbluth, is a wearable device that assists patients with Essential Tremor and Parkinson’s. Proven 40 OS is a fertilizer using naturally occurring microbes to reduce emissions and pollution while producing higher crop yields – developed by Pivot Bio, founded by alumnus Karsten Temme.

Read More

Aluna named Tech for Global Good Laureate

photo of person using Aluna device

BioE startup Aluna, founded by alumna Charvi Shetty, has been named a 2023-24 Tech for Global Good Laureate, one of four venures recognized for using technology to significantly advance health equity and improve lives. Aluna makes hardware and software that helps people with breathing problems.

Read More

Wilbur Lam named to National Academy of Medicine

photo of Wilbur Lam in corridor

PhD alumnus Wilbur Lam, now Professor of Pediatrics and Biomedical Engineering, Emory University and Georgia Tech, has been named one of the 2023 new members of the National Academy of Medicine. Lam was recognized for “outstanding contributions in point-of-care, home-based, and/or smartphone-enabled diagnostics that are changing the management of pediatric and hematologic diseases as well as development of microsystems technologies as research-enabling platforms to investigate blood biophysics. He also leads national/NIH efforts to assess diagnostic tests (including those for COVID-19) for the entire country.”

Read More

Bolt Threads going public

Photo of Bolt Threads cofounders Dan Widmaier (left) and David Breslauer in their manufacturing facility

Bolt Threads, a company co-founded by BioE PhD alumnus David Breslauer, plans to go public in a SPAC deal that values the one-time unicorn at $250 million. Bolt Threads uses synthetic biology and other techniques to sustainably produce engineered biomaterials, including synthetic spider silk and mushroom-based faux leather.

Read More